K.P.R. Mill Limited Investor Presentation for Un-Audited Financial Results of Q3 FY26
K.P.R. Mill Limited has submitted its investor presentation detailing the Un-Audited Financial Results for the quarter ended December 31, 2025…
IRCON International Limited Q3 & 9M FY26 Financial Performance and Order Book Update
IRCON International Limited announced its financial results for Q3 and 9M FY26 on February 11, 2026. Consolidated Operating Revenue for Q3FY26…
Kirloskar Oil Engines Reports Strong Q3 FY26 Results with Robust Revenue and Profit Growth
Kirloskar Oil Engines (KOEL) announced robust financial results for the quarter ending December 31, 2025. Standalone net sales grew 35% YoY to…
Capri Global Capital Limited Withdrawal of Postal Ballot Notice for Director Re-appointment
Capri Global Capital Limited has decided to withdraw a previously issued Postal Ballot Notice dated January 13, 2026. This withdrawal pertains…
Bayer CropScience Limited Unaudited Financial Results and Limited Review Report for Q3 FY2026
Bayer CropScience Limited announced its Unaudited Financial Results for the quarter and nine months ended December 31, 2025, following a Board…
Welspun Enterprises Limited Transcript of Earnings Call for Q3 FY2026 Disclosed
Welspun Enterprises Limited has made available the official transcript of its recent Earnings Call. The call discussed the un-audited…
Garware Technical Fibres Q3FY26 Results Show 21.8% Growth in PBT
Garware Technical Fibres announced its unaudited results for Q3FY26, reporting a 21.8% increase in consolidated Profit Before Tax (PBT) to Rs.…
Hindalco Industries Novelis Reports Q3FY26 Results Amid Oswego Production Disruption
Novelis Inc., a wholly owned subsidiary of Hindalco Industries, reported its Q3FY26 results, showing resilience despite significant…
Bayer CropScience Reports Financial Results for Quarter Ending December 31, 2025
Bayer CropScience Limited has announced its Unaudited Financial Results for the quarter and nine months ending December 31, 2025. The Board of…
Orchid Pharma Limited Board Approves Unaudited Financial Results for Q3 FY2025 and Review Reports
Orchid Pharma Limited announced the approval of its Unaudited Standalone and Consolidated Financial Results for the quarter and nine months…